Tissue transglutaminase facilitates the polymerization of insulin-like growth factor-binding protein-1 (IGFBP-1) and leads to loss of IGFBP-1's ability to inhibit insulin-like growth factor-I-stimulated protein synthesis.
about
Tissue transglutaminase has intrinsic kinase activity: identification of transglutaminase 2 as an insulin-like growth factor-binding protein-3 kinasealpha 2-Macroglobulin: a new component in the insulin-like growth factor/insulin-like growth factor binding protein-1 axis.Proteomic profiling of amniotic fluid in preterm labor using two-dimensional liquid separation and mass spectrometry.Insulin-like growth factor binding protein-3 mediates vascular repair by enhancing nitric oxide generation.Interaction between insulin-like growth factor-1 and atherosclerosis and vascular aging.Aging, atherosclerosis, and IGF-1IGF binding protein-3 regulates hematopoietic stem cell and endothelial precursor cell function during vascular development.Diabetic microangiopathy: IGFBP control endothelial cell growth by a common mechanism in spite of their species specificity and tissue peculiarity.Transglutaminase type 2 affects cell migration through post-translational modification of platelet-derived growth factor-BB.Hypoxia alters phosphorylation status of insulin-like growth factor (IGF)-binding protein-1 and attenuates biological activities of IGF-I in HepG2 cell cultures.External GTP-bound transglutaminase 2 is a molecular switch for chondrocyte hypertrophic differentiation and calcification.Increases in free, unbound insulin-like growth factor I enhance insulin responsiveness in human hepatoma G2 cells in culture.Biological functionalities of transglutaminase 2 and the possibility of its compensation by other members of the transglutaminase family.
P2860
Q28255156-E9EC8D4C-8766-480C-AA89-1996F0BC181DQ31008087-55FB40A4-4DC7-42C5-BCD0-FA9B29795C4DQ33384672-C15BE0B0-3A23-4DA2-9CE9-D5DB8B7A7696Q33504506-ECB4D224-F962-4568-A307-7B94EBC56086Q34349858-3A04950E-08B2-493A-801F-5CAC072CDCDFQ35947440-DC972ACB-19AB-4E2B-947D-3FAA8FF73CEDQ35973411-DAA4F33F-6121-4A4F-A6D6-B867F7E1EB75Q36620111-F1618CF0-C806-4495-97A2-7A3BCE9864AAQ38746075-57233395-E9A1-4467-8EDB-1564A1CABF75Q39132512-06E32444-69C5-4937-8A00-7C5AC57C92B7Q40462021-10C61AAF-64C6-4D34-9709-C1B74712F53FQ42162185-89DF2FE9-96C9-464B-9CF8-2F78E24ED0EDQ55499802-8F588B65-9450-463F-816C-81DA837DD850
P2860
Tissue transglutaminase facilitates the polymerization of insulin-like growth factor-binding protein-1 (IGFBP-1) and leads to loss of IGFBP-1's ability to inhibit insulin-like growth factor-I-stimulated protein synthesis.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Tissue transglutaminase facili ...... -stimulated protein synthesis.
@en
type
label
Tissue transglutaminase facili ...... -stimulated protein synthesis.
@en
prefLabel
Tissue transglutaminase facili ...... -stimulated protein synthesis.
@en
P2093
P2860
P356
P1476
Tissue transglutaminase facili ...... -stimulated protein synthesis.
@en
P2093
P2860
P304
P356
10.1074/JBC.M008359200
P407
P577
2000-12-19T00:00:00Z